Company intelligence / Profile preview

Consultys

Ownership: Private
Development stage: Other

Overview

Consultys is an independent European consulting group specializing exclusively in the pharmaceutical laboratories and broader life sciences sector. It provides expert advisory services covering R&D strategy through industrial-scale production—including gene therapy/immunotherapy/cancerology/recombinant proteins/microbiota—primarily supporting large pharma manufacturers/labs across Europe. The company has no proprietary drug pipeline or platform technology but plays a key role as an external partner enabling successful product development/commercialization within regulated environments.

Modalities: Small moleculeRecombinant proteinGene therapyImmunotherapyMicrobiota (as related to biotech innovation)
Industry: Consulting

Beyond the preview

Go deeper on Consultys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Consultys.

Explore the full profile